Mark S. Gelder M.D., Chief Medical Officer at Onconova Therapeutics, Inc. (ONTX), bought 2,381 shares at $4.20 ($10K) on 2021-09-28, disclosed to the SEC on 2021-09-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.